{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:00:25Z","timestamp":1778274025016,"version":"3.51.4"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":4927,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1995,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>BACKGROUND AND OBJECTIVE <\/jats:bold> Degradation of AVP by placental vasopressinase may precipitate gestational diabetes insipidus, which in some cases is accompanied by pre\u2010eciampsia. Abnormally elevated vasopressinase has also been reported in pre\u2010eciampsia without diabetes Insipidus. This association between excessive vasopressinase production and pre\u2010eciampsia might be explained if the products of AVP degradation by vasopressinase retained pressor activity even after anti\u2010diuretic activity had been destroyed. Recent evidence indicates that such products may raise blood pressure in rats. The objective of this study was, therefore, to purify vasopressinase and investigate its action on both the V<jats:sub>1<\/jats:sub> and V<jats:sub>2<\/jats:sub> receptor\u2010stimulating activity of AVP.<\/jats:p><jats:p><jats:bold>DESIGN <\/jats:bold> Vasopressinase was purified from pooled pregnancy serum by ammonium sulphate precipitation, followed by sequential Ion exchange, lentil lectin affinity and gel filtration chromatography. Purified enzyme was then used to degrade AVP and the loss of both immunoreactivity and biological activity monitored. Loss of V<jats:sub>1<\/jats:sub> receptor\u2010stimulating activity and V<jats:sub>2<\/jats:sub> receptor\u2010stimulating activity was compared by two\u2010way ANOVA.<\/jats:p><jats:p><jats:bold>PATIENTS <\/jats:bold> Blood was obtained from healthy women between week 34 and the end of pregnancy. Pooled serum from 20\u201330 patients was used as starting material for the purification of vasopressinase.<\/jats:p><jats:p><jats:bold>MEASUREMENTS <\/jats:bold> AVP immunoreactivity was measured by radioimmunoassay, V<jats:sub>1<\/jats:sub> receptor\u2010stimulating activity by a platelet aggregation bioassay, and V<jats:sub>2<\/jats:sub> receptor\u2010stimulating activity by adenylate cyclase stimulation in LLC\u2010PK<jats:sub>1<\/jats:sub> target cells.<\/jats:p><jats:p><jats:bold>RESULTS <\/jats:bold> Purified vasopressinase was a dimeric protein of molecular weight 330 kDa, which cleaved the synthetic substrate S\u2010benzyl\u2010<jats:sc>l<\/jats:sc>\u2010cystelne\u20104\u2010nitroanilide with a <jats:italic>K<\/jats:italic><jats:sub>m<\/jats:sub> of 0\u00b733 mM. Incubation of AVP (0\u00b71 mm) with vasopressinase (0\u00b766 g\/I) at 37\u00b0C led to a parallel loss of both AVP immunoreactivity and biological activity. The rates of loss of V<jats:sub>1<\/jats:sub> and V<jats:sub>2<\/jats:sub> receptor mediated activities were not significantly different.<\/jats:p><jats:p><jats:bold>CONCLUSIONS <\/jats:bold> We report the first direct comparison between the loss of V<jats:sub>1<\/jats:sub> and V<jats:sub>2<\/jats:sub> receptor mediated activities of vasopresrinase degraded AVP. There was no significant retention of V<jats:sub>1<\/jats:sub>, relative to V<jats:sub>2<\/jats:sub>, receptor mediated activity. AVP degradation products are unlikely to be pathogenic in hypertensive pregnancy.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1995.tb02598.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T10:33:46Z","timestamp":1205750026000},"page":"51-58","source":"Crossref","is-referenced-by-count":24,"title":["Loss of biological activity of arginine vasopressin during its degradation by vasopressinase from pregnancy serum"],"prefix":"10.1111","volume":"42","author":[{"given":"M. P.","family":"Gordge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. J.","family":"Huggett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. N.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. H.","family":"Nelld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1003329"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6351252"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0021-9258(18)33011-4","article-title":"Proteolytic conversion of arginine\u2010vasopressin and oxytocin by brain synaptic membranes","volume":"258","author":"Burbach J.P.H.","year":"1983","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114017"},{"key":"e_1_2_1_6_1","first-page":"F348","article-title":"Metabolic clearance of vasopressin and an analogue resistant to vasopressinase in human pregnancy","volume":"264","author":"Davison J.M.","year":"1993","journal-title":"American Journal of Physiology"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/clinchem\/22.1.79","article-title":"Spectrophotometric end\u2010point method for assay of serum cystyl\u2010aminopeptidase in pregnancy","volume":"22","author":"Durham B.H.","year":"1976","journal-title":"Clinical Chemistry"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.32.4.318"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704233161707"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs0830313"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/09537109409005518"},{"key":"e_1_2_1_12_1","first-page":"184","article-title":"Interrelationship between subpressor effects of vasopressin and other vasoactive hormones in the rat","volume":"10","author":"Ishikawa S.E.","year":"1984","journal-title":"Mineral and Electrolyte Metabolism"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb08384.x"},{"key":"e_1_2_1_14_1","first-page":"S38","article-title":"Mechanisms of action of vasopressin and vasopressin antagonists","volume":"34","author":"Jard S.","year":"1988","journal-title":"Kidney International"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-994651"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(90)90020-F"},{"key":"e_1_2_1_17_1","first-page":"789","article-title":"Transient diabetes insipidus of pregnancy","volume":"44","author":"Krege J.H.","year":"1989","journal-title":"Obstetrics and Gynecology Survey"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000469343","article-title":"Purification and characterization of human placental microsomal aminopeptidase: immunological difference between placental microsomal aminopeptidase and pregnancy serum cystyl\u2010aminopeptidase","volume":"35","author":"Kurauchi O.","year":"1986","journal-title":"Enzyme"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0020-711X(85)90013-8"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4838(86)90045-2"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0020-711X(88)90189-9"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1988.tb12802.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-8129-1_8"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/308652a0"},{"key":"e_1_2_1_25_1","first-page":"135","article-title":"In vitro degradation of angiotensin II (A\u2010II) by human placental subcellular fractions, pregnancy sera and purified placental aminopeptidases","volume":"110","author":"Mizutani S.","year":"1985","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1210503"},{"key":"e_1_2_1_27_1","first-page":"425","article-title":"Half\u2010life of oxytocin in blood of pregnant and non\u2010pregnant women","volume":"61","author":"Ryden G.","year":"1969","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_1_28_1","first-page":"65","article-title":"Degradation of oxytocin, lysine\u2010vasopressin, angiotensin II and angiotensin\u2010II\u2010amide by oxytocinase (cystine aminopeptidase)","volume":"4","author":"Sjoholm I.","year":"1967","journal-title":"Acta Pharmaceutica Suecica"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(77)90306-4"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112179"},{"key":"e_1_2_1_31_1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/clinchem\/19.7.756","article-title":"Evaluation of S\u2010benzyl\u2010l\u2010cysteine\u20134\u2032\u2010nitroanilide as a substrate for serum cysteine aminopeptidase","volume":"19","author":"Tovey J.E.","year":"1973","journal-title":"Clinical Chemistry"},{"key":"e_1_2_1_32_1","first-page":"67","volume-title":"Handbook of Experimental Pharmacology","author":"Tuppy H.","year":"1968"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb02140.x"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-116-2-738"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1995.tb02598.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1995.tb02598.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T06:04:08Z","timestamp":1698300248000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1995.tb02598.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.1111\/j.1365-2265.1995.tb02598.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb02598.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}